Last kr199.40 SEK
Change Today -0.10 / -0.05%
Volume 385.4K
GETIB On Other Exchanges
Symbol
Exchange
Stockholm
OTC US
OTC US
Berlin
As of 11:30 AM 05/21/13 All times are local (Market data is delayed by at least 15 minutes).

getinge ab-b shs (GETIB) Snapshot

Open
kr199.00
Previous Close
kr199.50
Day High
kr199.40
Day Low
kr197.70
52 Week High
01/3/13 - kr225.10
52 Week Low
06/28/12 - kr165.40
Market Cap
47.5B
Average Volume 10 Days
475.1K
EPS TTM
kr9.58
Shares Outstanding
222.4M
EX-Date
03/22/13
P/E TM
20.8x
Dividend
kr4.15
Dividend Yield
2.08%
Current Stock Chart for GETINGE AB-B SHS (GETIB)

Related News

No related news articles were found.

getinge ab-b shs (GETIB) Related Businessweek News

No Related Businessweek News Found

getinge ab-b shs (GETIB) Details

Getinge AB, a medical technology company, engages in the provision of medical technical equipment for surgery, intensive care, infection control, and care ergonomics primarily in Western Europe, the United States, and Canada. The company operates in three segments: Medical Systems, Extended Care, and Infection Control. The Medical Systems segment offers surgical workstation systems and products under the Maquet brand for cardio surgery and intensive care. Its product portfolio includes surgical tables, surgical lamps, telemedicine, and perfusion products, instruments for bypass operations, ventilators, anaesthesia systems, and synthetic vascular implants and stents. The Extended Care segment provides systems for hygiene and the lifting of elderly and disabled persons, as well as products that prevent and treat pressure ulcers under the ArjoHuntleigh brand name. This segment offers bathing and shower solutions, lifting equipment, and mattresses for the treatment and prevention of pressure sores, as well as consulting services. The Infection Control segment supplies systems for preventing the occurrence and spread of infection under the Getinge brand name. Its product range includes disinfectors, sterilizers, documentation systems, IT systems, and related equipment. This segment serves hospitals and homes for the elderly, the pharmaceuticals industry, and laboratories. The company was founded in 1904 and is headquartered in Getinge, Sweden.

14,919 Employees
Last Reported Date: 02/25/13
Founded in 1904

getinge ab-b shs (GETIB) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

getinge ab-b shs (GETIB) Key Developments

Getinge AB Reports Consolidated and Parent Earnings Results for the First Quarter Ended March 31, 2013; Provides Earnings Guidance for 2013

Getinge AB reported consolidated and parent earnings results for the first quarter ended March 31, 2013. For the quarter, on consolidated basis, the company's net sales were SEK 5,664 million against SEK 5,246 million last year. Operating profit was SEK 400 million against SEK 704 million last year. Profit before tax was SEK 252 million against SEK 570 million last year. Net profit attributable to parent company's shareholders was SEK 182 million against SEK 420 million last year. Earnings per share were SEK 0.76 against SEK 1.76 last year. EBITDA was SEK 862 million against SEK 1,123 million last year. Cash flow from operations SEK 366 million against SEK 722 million last year. Investments in tangible fixed assets were SEK 200 million against SEK 166 million last year. Net interest-bearing debt was SEK 18,395 million against SEK 16,325 million at March 31, 2012. EBITA before restructuring, integration and acquisition costs was SEK 792 million against SEK 854 million last year. EBITA was SEK 551 million against SEK 854 million last year. Return on equity was 15.2% against 17.2% last year. EBITA was charged with SEK 130 million from the effects of the recently introduced Medical Device Tax in the US and the adverse exchange-rate effects in the wake of the SEK's continued rise against most currencies. Excluding the tax and negative exchange-rate effects, the group's EBITA rose by nearly 8%. For the quarter, on parent basis, the company's operating loss was SEK 33 million against SEK 26 million last year. Profit after financial items was SEK 80 million against SEK 255 million last year. Profit before tax was SEK 80 million against SEK 255 million last year. Net profit was SEK 77 million against SEK 185 million last year. In 2013, overall, organic volume growth is expected to remain in line with that of 2012 or possibly somewhat better. Profit growth, excluding restructuring costs, is expected to be favorable in the current year, even in consideration of the introduction of the Medical Device Tax in the US at year-end 2012 and negative transaction effects, which, when combined, are expected to total SEK 230 million.

Getinge AB, Q1 2013 Earnings Call, Apr 17, 2013

Getinge AB, Q1 2013 Earnings Call, Apr 17, 2013

Getinge AB Declares Dividend for 2012

Getinge AB announced that at the AGM held on March 21, 2013, the shareholders resolved to declare a dividend of SEK 4.15 per share. March 26, 2013 was determined as record date for dividend.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GETIB:SS kr199.40 SEK -0.10

GETIB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CareFusion Corp $34.13 USD +0.03
CR Bard Inc $106.71 USD -0.26
Hospira Inc $35.92 USD -0.11
Mettler-Toledo International Inc $223.39 USD +0.28
Varian Medical Systems Inc $69.88 USD +0.43
View Industry Companies
 

Industry Analysis

GETIB

Industry Average

Valuation GETIB Industry Range
Price/Earnings 20.4x
Price/Sales 1.9x
Price/Book 3.1x
Price/Cash Flow 19.1x
TEV/Sales 1.7x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GETINGE AB-B SHS, please visit www.getingegroup.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.